News | May 13, 2026
Mankind’s Rajeev Juneja contributes Rs. 9.17 crore to National Defence Fund
This marks the second consecutive year that Juneja has made a personal contribution towards supporting the armed forces
This marks the second consecutive year that Juneja has made a personal contribution towards supporting the armed forces
Paves way for CNS cancer test rollout
75 bikers participated in the rally organised by Thalassemia and Sickle Cell Society to promote early screening and voluntary blood donation
The once-daily oral therapy is the first and only tyrosine kinase 2 (TYK2) inhibitor approved in the European Union for this indication, marking a significant expansion of its immunology portfolio
Steinhagen brings more than 25 years of leadership experience spanning pharma, biotech and the CRO/CDMO sector
The move targets long-standing bottlenecks in MSC science, including cell-to-cell variability, immunocompatibility concerns, and inefficient manufacturing workflows
Offers a non-surgical treatment option for tricuspid regurgitation, a commonly underdiagnosed heart valve disorder linked to heart failure
Initiative launched with Tata 1mg to benefit 70,000 people across 70 remote villages in Kalahandi region
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
The company plans to collaborate with European medical centres to expand adoption of its robotic microsurgery platform
Subscribe To Our Newsletter & Stay Updated
